Quince Therapeutics, Inc. (QNCX) M&A Call Prepared Remarks Transcript

Quince Therapeutics, Inc. (QNCX) M&A Call May 18, 2026 10:00 AM EDTCompany ParticipantsDirk Thye - CEO, Chief Medical Officer & DirectorBrigette...